搜索筛选:
搜索耗时1.4991秒,为你在为你在102,285,761篇论文里面共找到 6 篇相符的论文内容
发布年度:
[会议论文] 作者:J.Hu,Y.Zhou,X.Sheng,
来源:2014年光子与光学工程国际会议暨西部光子学学术会议 年份:2014
Tunable optical diffusers based on multifunctional fillers of nano(ZnO-TiO2)@polysiloxane were successfully prepared by simple UV curing process.The tunable...
[会议论文] 作者:L.Si,X.Wang,B.Lian,Y.Kong,Z.Chi,C.Cui,X.Sheng,J Guo,
来源:第十七届全国临床肿瘤学大会暨2014年CSCO学术年会 年份:2014
...
Primary malignant melanoma of the esophagus: clinical features, signaling pathway, management and su
[会议论文] 作者:X.Wang,L.Si,Y.Kong,Z.Chi,X.Sheng,C.Cui,L.Mao,B.Lian,J Guo,
来源:第十七届全国临床肿瘤学大会暨2014年CSCO学术年会 年份:2014
...
Primary malignant melanoma of the esophagus: clinical features, signaling pathway, management and su
[会议论文] 作者:X.Wang,L.Si,Y.Kong,Z.Chi,X.Sheng,C.Cui,L.Mao,B.Lian,J Guo,
来源:第十七届全国临床肿瘤学大会暨2014年CSCO学术年会 年份:2014
Background: Primary malignant melanoma of the esophagus (PMME) is a rare disease that has a poor prognosis and develops multiple metastases in the early stage.Treatment protocols are not well-establis...
[会议论文] 作者:X.Wang,Y.Kong,X.Yan,L Mao,B.Lian,Z.Chi,L.Si,C.Cui,X.Sheng,J Guo,
来源:第十八届全国临床肿瘤学大会暨2015年CSCO学术年会 年份:2015
目的: BRAF/NRAS mutations are predictors of poor prognosis in melanoma.High-dose interferon (HDI) is the only drug approved by FDA as adjuvant therapy in hig...
[会议论文] 作者:X.Wang,L Mao,Y.Kong,Z.Chi,X.Sheng,C.Cui,B.Lian,X.Yan,L.Si,J Guo,
来源:第十八届全国临床肿瘤学大会暨2015年CSCO学术年会 年份:2015
目的: BRAF/NRAS mutations are predictors of poor prognosis in melanoma.High-dose interferon (HDI) is the only drug approved by FDA as adjuvant therapy in high risk resected melanomas....
相关搜索: